Dr. Rowida Abdalla in Lexington, Kentucky
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Healthcare Policy & Access | Prescriptions
FDA’s compounded GLP-1 crackdown: What changed after Ozempic, Wegovy, Mounjaro, and Zepbound shortages ended
With semaglutide and tirzepatide shortages resolved, the FDA is tightening scrutiny of mass-marketed compounded GLP-1s. Here is what changed and what patients should ask now.
-
Invisalign in the Digital Age: A New Frontier in Orthodontics
Invisalign, a groundbreaking orthodontic treatment, has revolutionized the field of dentistry in the digital age. Gone are the days of traditional metal braces as Invisalign offers a new frontier in…
-
Empower Your Dental Practice: Share Expertise with Weence
Empower Your Dental Practice: Share Expertise with Weence
-
CDC guidance puts HIV and STI screening in focus
New CDC and USPSTF guidance is a reminder that sexual-health screening is part of routine preventive care, not just care after symptoms or a known exposure. For many adults, adolescents, and pregnant people, the key questions are when to test, how often to repeat testing, and which infections should be included.
